ARWR Net Income Growth
Arrowhead Pharmaceuticals Inc · Net Income Growth
ARWR Net Income Growth
Year-over-year change vs the same period a year earlier
Latest reported-115.58%period ending
ARWR TTM Net Income YoY % (1198.58% → -115.58%)
Year-over-year change
High-resolution chart · PNG
ARWR net income growth history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | Net Income Growth |
|---|---|
| -115.5757% | |
| -109.0117% | |
| 131.618% | |
| 99.7279% | |
| 72.4458% | |
| 69.4196% | |
| -115.5269% | |
| -192.0438% | |
| -197.4131% | |
| -213.4268% | |
| -92.0927% | |
| -16.5918% | |
| -17.6585% | |
| -34.3485% | |
| 15.5595% | |
| -25.0021% | |
| -22.254% | |
| -2.0168% | |
| -78.3305% | |
| -66.5801% | |
| -415.6921% | |
| -1,249.7919% | |
| -292.6453% | |
| -224.3882% | |
| -153.6493% | |
| -0.3693% | |
| 282.3234% | |
| 224.8379% | |
| 183.6232% | |
| 121.5789% | |
| 17.69% | |
| -58.377% | |
| -18.641% | |
| 25.826% | |
| 52.3869% | |
| 57.9307% | |
| 45.5507% | |
| 25.9884% | |
| 15.89% | |
| 11.1112% | |
| 6.0045% | |
| 5.3437% | |
| -25.5755% | |
| -56.8108% | |
| -79.6398% | |
| -92.4103% | |
| -89.9409% | |
| -88.2595% | |
| -119.1628% | |
| -79.6876% | |
| -59.7855% | |
| -47.4174% | |
| -22.4653% | |
| -98.7351% | |
| -456.7682% | |
| -575.1903% | |
| -688.8404% | |
| -1,268.1243% | |
| 26.2952% | |
| 45.8112% | |
| 67.4069% | |
| 90.3318% | |
| 55.807% | |
| 70.0957% | |
| 70.4979% | |
| 68.1565% | |
| 57.0937% | |
| 28.7225% | |
| 5.7558% | |
| 4.8373% | |
| 4.9972% | |
| 9.4954% | |
| 16.4901% | |
| -36.0391% | |
| -44.35% | |
| -41.0351% | |
| -105.6983% | |
| -62.7497% | |
| -166.3644% | |
| -221.2123% | |
| -180.8941% | |
| -357.0141% | |
| -112.3183% | |
| -164.6031% | |
| -490.9963% | |
| -835.7234% | |
| -1,404.8209% | |
| -2,521.7917% | |
| -216.5208% | |
| -1.403% | |
| -12.2852% | |
| 61.3179% | |
| -29.5191% | |
| -93.216% | |
| -9.5191% | |
| -32.4969% | |
| -146.9491% | |
| -45.2464% | |
| -76.9515% | |
| -35.0915% |